Valentine4
Bluelighter
- Joined
- Oct 26, 2007
- Messages
- 76
Hey all. I haven't posted in a while, but I happened to be doing some research on clonazepam and it's bioavailability intranasally. Before I begin - here is the chart, from the study I reference below, illustrating my points (you'll see the diagram again late in this post):

After checking the journals and studies, I came back to Bluelight and realized that everyone was saying that when you "snort" Clonazepam, that it is ineffective.
The primiere study on this exact subject* found directly contradict the notion that intranasal administration is ineffectual/wasteful. Quite the contrary, the study found that Intranasal administration is a comparable Route of Administration (ROA) to Buccal - and actually superior in achieving higher plasma levels faster. The plasma level testing shows that Intransal administration provides higher plasma concentrations sooner than Buccal.
However, the study ultimately concluded that (since the levels were still similiar), that the time and effort it would take to develop a Intranasal preparation would not be worth the effort - as the studies purpose was to see if Intransal was a viable alternative ROA to Intravenous (IV) administration. Fhey weren't looking for something to replace buccal or oral administration.
So, clinically, the higher Intranasal-resultant plasma concentrations may not be worth it versus existing buccal preparations...
. ..But but if you want it for recreational purposes, it seems Intranasal is very viable and, from the data, the preferable ROA for recreational use (if you are not administering it IV - please don't)
The sole stidy I could locate, that compares the Bioavailability of Intranasal vs Buccal Clonazepam, indicates near identically net-bioavailability over time - but it clearly shows the Plasma levels are higher sooner when Clonazepam's ROA is Intranasal, vs when it's ROA is Buccal.


*Study:
Absorption of clonazepam after intranasal and buccal administration.
M W Schols-Hendriks, J J Lohman, R Janknegt, J J Korten, F W Merkus, and P M Hooymans
Abstract
Serum concentrations of clonazepam after intranasal, buccal and intravenous administration were compared in a cross-over study in seven healthy male volunteers. Each subject received a 1.0 mg dose of clonazepam intranasally and buccally and 0.5 mg intravenously. A Cmax of 6.3 +/- 1.0 ng ml-1 (mean; +/- s.d.) was measured 17.5 min (median) (range 15-20 min) after intranasal administration. A second peak (4.6 +/- 1.3 ng ml-1) caused by oral absorption was seen after 1.7 h (range 0.7-3.0 h). After buccal administration a Cmax of 6.0 +/- 3.0 ng ml-1 was measured after 50 min (range 30-90 min) with a second peak of 6.5 +/- 2.5 ng ml-1 after 3.0 h (range 2.0-4.0 h). Two minutes after i.v. injection of 0.5 mg clonazepam the serum concentration was 27 +/- 18 ng ml-1. It is concluded that intranasal clonazepam is an alternative to buccal administration. However, the Cmax of clonazepam after intranasal administration is not high enough to recommend the intranasal route as an alternative to intravenous injection.

After checking the journals and studies, I came back to Bluelight and realized that everyone was saying that when you "snort" Clonazepam, that it is ineffective.
The primiere study on this exact subject* found directly contradict the notion that intranasal administration is ineffectual/wasteful. Quite the contrary, the study found that Intranasal administration is a comparable Route of Administration (ROA) to Buccal - and actually superior in achieving higher plasma levels faster. The plasma level testing shows that Intransal administration provides higher plasma concentrations sooner than Buccal.
However, the study ultimately concluded that (since the levels were still similiar), that the time and effort it would take to develop a Intranasal preparation would not be worth the effort - as the studies purpose was to see if Intransal was a viable alternative ROA to Intravenous (IV) administration. Fhey weren't looking for something to replace buccal or oral administration.
So, clinically, the higher Intranasal-resultant plasma concentrations may not be worth it versus existing buccal preparations...
. ..But but if you want it for recreational purposes, it seems Intranasal is very viable and, from the data, the preferable ROA for recreational use (if you are not administering it IV - please don't)
The sole stidy I could locate, that compares the Bioavailability of Intranasal vs Buccal Clonazepam, indicates near identically net-bioavailability over time - but it clearly shows the Plasma levels are higher sooner when Clonazepam's ROA is Intranasal, vs when it's ROA is Buccal.


*Study:
Absorption of clonazepam after intranasal and buccal administration.
M W Schols-Hendriks, J J Lohman, R Janknegt, J J Korten, F W Merkus, and P M Hooymans
Abstract
Serum concentrations of clonazepam after intranasal, buccal and intravenous administration were compared in a cross-over study in seven healthy male volunteers. Each subject received a 1.0 mg dose of clonazepam intranasally and buccally and 0.5 mg intravenously. A Cmax of 6.3 +/- 1.0 ng ml-1 (mean; +/- s.d.) was measured 17.5 min (median) (range 15-20 min) after intranasal administration. A second peak (4.6 +/- 1.3 ng ml-1) caused by oral absorption was seen after 1.7 h (range 0.7-3.0 h). After buccal administration a Cmax of 6.0 +/- 3.0 ng ml-1 was measured after 50 min (range 30-90 min) with a second peak of 6.5 +/- 2.5 ng ml-1 after 3.0 h (range 2.0-4.0 h). Two minutes after i.v. injection of 0.5 mg clonazepam the serum concentration was 27 +/- 18 ng ml-1. It is concluded that intranasal clonazepam is an alternative to buccal administration. However, the Cmax of clonazepam after intranasal administration is not high enough to recommend the intranasal route as an alternative to intravenous injection.
Last edited: